WallStreetZenWallStreetZen

NASDAQ: CLRB
Cellectar Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for CLRB

Based on 2 analysts offering 12 month price targets for Cellectar Biosciences Inc.
Min Forecast
$12.00+268.1%
Avg Forecast
$20.00+513.5%
Max Forecast
$28.00+758.9%

Should I buy or sell CLRB stock?

Based on 2 analysts offering ratings for Cellectar Biosciences Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CLRB stock forecasts and price targets.

CLRB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-03-28

1 of 1

Forecast return on equity

Is CLRB forecast to generate an efficient return?
Company
174.68%
Industry
76.05%
Market
78.64%
CLRB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CLRB forecast to generate an efficient return on assets?
Company
106.52%
Industry
30.84%
CLRB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CLRB earnings per share forecast

What is CLRB's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.51
Avg 2 year Forecast
-$0.67
Avg 3 year Forecast
$0.31

CLRB revenue forecast

What is CLRB's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$71.2M
Avg 2 year Forecast
$129.6M
Avg 3 year Forecast
$217.1M

CLRB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLRB$3.26$20.00+513.50%Strong Buy
COYA$8.00$14.00+75.00%Strong Buy
SEER$1.81N/AN/A
CTMX$1.49$5.77+287.45%Strong Buy
CTXR$0.64$4.00+523.05%Buy

Cellectar Biosciences Stock Forecast FAQ

Is Cellectar Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CLRB) stock is to Strong Buy CLRB stock.

Out of 2 analysts, 1 (50%) are recommending CLRB as a Strong Buy, 1 (50%) are recommending CLRB as a Buy, 0 (0%) are recommending CLRB as a Hold, 0 (0%) are recommending CLRB as a Sell, and 0 (0%) are recommending CLRB as a Strong Sell.

If you're new to stock investing, here's how to buy Cellectar Biosciences stock.

What is CLRB's earnings growth forecast for 2024-2026?

(NASDAQ: CLRB) Cellectar Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.62%.

Cellectar Biosciences's earnings in 2024 is -$50,983,866.On average, 2 Wall Street analysts forecast CLRB's earnings for 2024 to be -$54,131,875, with the lowest CLRB earnings forecast at -$54,490,364, and the highest CLRB earnings forecast at -$53,773,386. On average, 3 Wall Street analysts forecast CLRB's earnings for 2025 to be -$24,018,779, with the lowest CLRB earnings forecast at -$46,603,601, and the highest CLRB earnings forecast at $18,641,440.

In 2026, CLRB is forecast to generate $10,933,922 in earnings, with the lowest earnings forecast at -$12,905,613 and the highest earnings forecast at $34,773,456.

What is CLRB's revenue growth forecast for 2025-2027?

(NASDAQ: CLRB) Cellectar Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.78%.

Cellectar Biosciences's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast CLRB's revenue for 2025 to be $2,551,009,432, with the lowest CLRB revenue forecast at $856,789,284, and the highest CLRB revenue forecast at $4,245,229,580. On average, 2 Wall Street analysts forecast CLRB's revenue for 2026 to be $4,646,558,284, with the lowest CLRB revenue forecast at $2,638,480,806, and the highest CLRB revenue forecast at $6,654,635,762.

In 2027, CLRB is forecast to generate $7,782,263,667 in revenue, with the lowest revenue forecast at $4,520,549,316 and the highest revenue forecast at $11,043,978,017.

What is CLRB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CLRB) forecast ROA is 106.52%, which is higher than the forecast US Biotechnology industry average of 30.84%.

What is CLRB's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CLRB price target, the average CLRB price target is $20.00, with the highest CLRB stock price forecast at $28.00 and the lowest CLRB stock price forecast at $12.00.

On average, Wall Street analysts predict that Cellectar Biosciences's share price could reach $20.00 by Mar 28, 2025. The average Cellectar Biosciences stock price prediction forecasts a potential upside of 513.5% from the current CLRB share price of $3.26.

What is CLRB's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: CLRB) Cellectar Biosciences's current Earnings Per Share (EPS) is -$3.08. On average, analysts forecast that CLRB's EPS will be -$1.51 for 2024, with the lowest EPS forecast at -$1.52, and the highest EPS forecast at -$1.50. On average, analysts forecast that CLRB's EPS will be -$0.67 for 2025, with the lowest EPS forecast at -$1.30, and the highest EPS forecast at $0.52. In 2026, CLRB's EPS is forecast to hit $0.31 (min: -$0.36, max: $0.97).

What is CLRB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CLRB) forecast ROE is 174.68%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.